Burden of Heart Failure in Latin America: A Systematic Review and Meta-analysis.

[1]  M. G. Crespo-Leiro,et al.  Adecuación en España a las recomendaciones terapéuticas de la guía de la ESC sobre insuficiencia cardiaca: ESC Heart Failure Long-term Registry , 2015 .

[2]  A. Bayés‐Genís,et al.  Adherence to the ESC Heart Failure Treatment Guidelines in Spain: ESC Heart Failure Long-term Registry. , 2015, Revista espanola de cardiologia.

[3]  Jiang He,et al.  Multiple Cardiometabolic Risk Factors in the Southern Cone of Latin America: A Population-based Study in Argentina, Chile, and Uruguay , 2015, International journal of cardiology.

[4]  V. Roger,et al.  Understanding the Epidemic of Heart Failure: Past, Present, and Future , 2014, Current Heart Failure Reports.

[5]  K. Padrón,et al.  Gated SPECT Myocardial Perfusion Imaging, Intraventricular Synchronism, and Cardiac Events in Heart Failure , 2014, Clinical nuclear medicine.

[6]  L. F. Junqueira,et al.  Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  A. Arias-Mendoza,et al.  PROGNOSIS OF ACUTE DECOMPENSATED HEART FAILURE IN PATIENTS WITH PRESERVED AND REDUCED LEFT VENTRICULAR EJECTION FRACTION BASED ON N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE AT ADMISSION , 2014 .

[8]  M. Geller,et al.  O194 Heart failure in Brazilian population. An overview about the last 11 years official epidemiological data , 2014 .

[9]  D. Giunta,et al.  Iceberg Phenomenon of Heart Failure in Hospitalized Patients: A Multicentric Cross Sectional Study , 2013 .

[10]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[11]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[12]  E. Bocchi,et al.  Chagas' cardiomyopathy: the economic burden of an expensive and neglected disease. , 2013, International journal of cardiology.

[13]  E. Bocchi,et al.  The reality of heart failure in Latin America. , 2013, Journal of the American College of Cardiology.

[14]  V. Roger.  Epidemiology of Heart Failure , 2013, Circulation research.

[15]  D. Albuquerque,et al.  Correlation of Clinical Parameters, Medication Therapy and Morbimortality with Angiotensin Converting Enzyme Genetic Polymorphisms in Patients with Non-Ischemic Heart Failure , 2013 .

[16]  K. Ruschel,et al.  Evaluation of Clinical Outcomes One Year after Completion of Nurse Management Program Based on Home Visits and Telephone Contacts , 2013 .

[17]  R. Bestetti,et al.  Outcome of Chagas cardiomyopathy in comparison to ischemic cardiomyopathy. , 2013, International journal of cardiology.

[18]  Á. Avezum,et al.  Acute coronary syndrome behavior: results of a Brazilian registry. , 2013, Arquivos brasileiros de cardiologia.

[19]  E. Bocchi,et al.  Mode of Death on Chagas Heart Disease: Comparison with Other Etiologies. A Subanalysis of the REMADHE Prospective Trial , 2013, PLoS neglected tropical diseases.

[20]  V. Roger,et al.  Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: a community study. , 2013, American journal of epidemiology.

[21]  H. Krumholz,et al.  National trends in heart failure hospital stay rates, 2001 to 2009. , 2013, Journal of the American College of Cardiology.

[22]  Leora I. Horwitz,et al.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. , 2013, JAMA.

[23]  P. Perel,et al.  Major Cardiovascular Risk Factors in Latin America: A Comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO) , 2013, PloS one.

[24]  Francisco Rogerlândio Martins-Melo,et al.  Multiple causes of death related to Chagas' disease in Brazil, 1999 to 2007. , 2012, Revista da Sociedade Brasileira de Medicina Tropical.

[25]  E. Colín-Ramírez,et al.  Cachexia assessed by bioimpedance vector analysis as a prognostic indicator in chronic stable heart failure patients. , 2012, Nutrition.

[26]  G. R. Aispuru,et al.  Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure. , 2012, European journal of internal medicine.

[27]  E. Colín-Ramírez,et al.  Bioelectrical impedance phase angle as a prognostic marker in chronic heart failure. , 2012, Nutrition.

[28]  A. Ribeiro,et al.  Different prognostic impact of the tissue Doppler-derived E/e' ratio on mortality in Chagas cardiomyopathy patients with heart failure. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[29]  F. S. Silveira,et al.  Insuficiência renal aguda em pacientes internados por insuficiência cardíaca descompensada - Reincade , 2012 .

[30]  G. Filippatos,et al.  A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial , 2012, Heart Failure Reviews.

[31]  Á. S. Liprandi,et al.  Economic and Financial Crisis in Argentina: A Novel Risk Factor for Cardiovascular Mortality? , 2012 .

[32]  E. Colín-Ramírez,et al.  Malnutrition syndrome, but not body mass index, is associated to worse prognosis in heart failure patients. , 2011, Clinical nutrition.

[33]  W. Almahmeed,et al.  Prevalence of heart failure with preserved ejection fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER study (Identification of Patients With Heart Failure and PREserved Systolic Function: an epidemiological regional study). , 2011, The American journal of cardiology.

[34]  A. Ciapponi,et al.  PRM2 EROS: A New Software For Early Stage Of Systematic REVIEWS , 2011 .

[35]  J. Gagliardino,et al.  Hospitalization costs for heart failure in people with type 2 diabetes: cost-effectiveness of its prevention measured by a simulated preventive treatment. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[36]  Sérgio Salles Xavier,et al.  I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica: resumo executivo , 2011 .

[37]  J. Marin Neto,et al.  I Diretriz Latino-Americana para o diagnóstico e tratamento da cardiopatia chagásica: resumo executivo , 2011 .

[38]  L. Correia,et al.  Prevalence and prognostic value of ventricular dyssynchrony in Chagas cardiomyopathy. , 2011, Arquivos brasileiros de cardiologia.

[39]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[40]  M. Ochiai,et al.  Predictors of low cardiac output in decompensated severe heart failure , 2011, Clinics.

[41]  M. Ochiai,et al.  [Anemia in patients with advanced heart failure]. , 2010, Arquivos brasileiros de cardiologia.

[42]  M. Ochiai,et al.  [Chagas cardiomyopathy: prognosis in clinical and hemodynamic profile C]. , 2010, Arquivos brasileiros de cardiologia.

[43]  D. Ferrante,et al.  Long-term results after a telephone intervention in chronic heart failure: DIAL (Randomized Trial of Phone Intervention in Chronic Heart Failure) follow-up. , 2010, Journal of the American College of Cardiology.

[44]  K. Santos,et al.  Impact of β-2 Thr164Ile and combined β-adrenergic receptor polymorphisms on prognosis in a cohort of heart failure outpatients , 2010 .

[45]  G. Aliti,et al.  Adherence of patients with heart failure to pharmacological and non-pharmacological treatment in a teaching hospital , 2010 .

[46]  M. Martins,et al.  Use of comorbidity measures to predict the risk of death in Brazilian in-patients. , 2010, Revista de saude publica.

[47]  E. Bocchi,et al.  Anemia and renal failure as predictors of risk in a mainly non-ischemic heart failure population. , 2010, International journal of cardiology.

[48]  C. O'connor,et al.  Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. , 2010, American heart journal.

[49]  R. Bestetti,et al.  Prognostic impact of Chagas' disease in patients awaiting heart transplantation. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  M. Moreira,et al.  [Single cardiac troponin T measurement predicts risk for adverse outcome in decompensated heart failure]. , 2010, Arquivos brasileiros de cardiologia.

[51]  C. Belziti,et al.  Empeoramiento de la función renal en pacientes hospitalizados por insuficiencia cardiaca aguda descompensada: incidencia, predictores y valor pronóstico , 2010 .

[52]  J. Solari,et al.  Caracteristicas Clinicas de los pacientes con insuficiencia cardiaca en un servicio de Medicina Interna , 2009 .

[53]  A. Herrera,et al.  Enfermedades del corazón y sus características epidemiológicas en la población cubana de 15 años y más Heart diseases and its epidemiologic features in Cuban population aged 15 and more , 2009 .

[54]  Augusto Hasiak Santo.  Tendência da mortalidade relacionada à doença de Chagas, Estado de São Paulo, Brasil, 1985 a 2006: estudo usando causas múltiplas de morte , 2009 .

[55]  P. Oberti,et al.  Prospective validation of the prognostic usefulness of B-type natriuretic peptide in asymptomatic patients with chronic severe aortic regurgitation. , 2009, Journal of the American College of Cardiology.

[56]  K. Santos,et al.  Aggregated Genetic Polymorphisms of Beta-Receptors and Heart Failure Mortality in a Cohort of Heart Failure Outpatients , 2009 .

[57]  H. Middlekauff,et al.  Increased muscle sympathetic nerve activity predicts mortality in heart failure patients. , 2009, International journal of cardiology.

[58]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[59]  A. Dobson,et al.  Understanding the ‘epidemic of heart failure’: a systematic review of trends in determinants of heart failure , 2009, European journal of heart failure.

[60]  J. Ramires,et al.  Cardiac troponin T for risk stratification in decompensated chronic heart failure. , 2009, Arquivos brasileiros de cardiologia.

[61]  M. Cagy,et al.  Seasonal variation in hospitalizations due to heart failure in Niterói city, Southeastern Brazil. , 2009, Revista de saude publica.

[62]  K. Swedberg,et al.  Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. , 2008, Journal of the American College of Cardiology.

[63]  J. Ramires,et al.  Hospital readmissions and death from Heart Failure--rates still alarming. , 2008, Arquivos brasileiros de cardiologia.

[64]  R. Kronmal,et al.  Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. , 2008, Archives of internal medicine.

[65]  S. Berra,et al.  Instrumento para la lectura crtica y la evaluacin de estudios epidemiolgicos transversales , 2008 .

[66]  R. Saraiva,et al.  Tissue Doppler imaging as a long-term prognostic index in left ventricular systolic dysfunction. , 2008, Arquivos brasileiros de cardiologia.

[67]  R. Bestetti,et al.  Predictors of all-cause mortality in chronic Chagas' heart disease in the current era of heart failure therapy. , 2008, International journal of cardiology.

[68]  A. Ribeiro,et al.  Right ventricular dysfunction is an independent predictor of survival in patients with dilated chronic Chagas' cardiomyopathy. , 2008, International journal of cardiology.

[69]  P. Leiva.  Faculty Opinions recommendation of Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. , 2008 .

[70]  L. F. Moreira,et al.  Long-Term Prospective, Randomized, Controlled Study Using Repetitive Education at Six-Month Intervals and Monitoring for Adherence in Heart Failure Outpatients: The REMADHE Trial , 2008, Circulation. Heart failure.

[71]  R. Bonafede,et al.  Insuficiencia cardíaca. Análisis observacional de base de datos , 2008 .

[72]  Roque Aras Júnior,et al.  Is Chagas cardiomyopathy an independent risk factor for patients with heart failure? , 2008, International journal of cardiology.

[73]  Claudio Hadid,et al.  Long-term follow-up of patients with indication for a implantable defibrillator for primary prevention of death. , 2008, Arquivos brasileiros de cardiologia.

[74]  A. Folsom,et al.  Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). , 2008, The American journal of cardiology.

[75]  Bruno Lococo,et al.  Predictores de insuficiencia cardiaca en la miocardiopatía chagásica crónica con disfunción asintomática del ventrículo izquierdo , 2008 .

[76]  T. Walther,et al.  Prognostic Value of Natriuretic Peptides in Chagas’ Disease: A 3-Year Follow-Up Investigation , 2007, Cardiology.

[77]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[78]  H. Grancelli.  Programas de tratamiento en la insuficiencia cardiaca. Experiencias del Estudio DIAL , 2007 .

[79]  K. Dickstein,et al.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.

[80]  D. Ferrante,et al.  Seasonal variation and trends in heart failure morbidity and mortality in a South American community hospital. , 2007, Congestive heart failure.

[81]  Á. Rojas,et al.  Factores de riesgo, manifestaciones clínicas y tratamiento de la insuficiencia cardiaca en mayores de 65 años , 2007 .

[82]  C. Yancy,et al.  Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE). , 2007, American heart journal.

[83]  J. Higgins,et al.  Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. , 2007, International journal of epidemiology.

[84]  L. Passos,et al.  Acute pulmonary embolism is an independent predictor of adverse events in severe decompensated heart failure patients. , 2007, Chest.

[85]  A. Carvalho,et al.  Evaluation of heart failure prognostic factors in patients referred for heart transplantation. , 2007, Arquivos brasileiros de cardiologia.

[86]  E. Mesquita,et al.  C-reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure. , 2007, Arquivos brasileiros de cardiologia.

[87]  G. Lalljie,et al.  Characteristics, treatment and short-term survival of patients with heart failure in a cardiology private practice in Jamaica. , 2007, The West Indian medical journal.

[88]  E. Cavalier,et al.  Estimated glomerular filtration rate. , 2007, Annals of internal medicine.

[89]  A. Lopes,et al.  Comparison of the effect of anemia on in-hospital mortality in patients with versus without preserved left ventricular ejection fraction. , 2006, The American journal of cardiology.

[90]  A. Mansur,et al.  Socioeconomic factors in the prognosis of heart failure in a Brazilian cohort. , 2006, International journal of cardiology.

[91]  L. Goldraich,et al.  A simple clinically based predictive rule for heart failure in-hospital mortality. , 2006, Journal of cardiac failure.

[92]  E. Perna,et al.  Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[93]  Pablo Castro G,et al.  [Predictors of hospital death and prolonged hospitalization in patients with cardiac failure in Chilean hospitals]. , 2006, Revista medica de Chile.

[94]  J. Ramires,et al.  O nível sérico de NT-proBNP é um preditor prognóstico em pacientes com insuficiência cardíaca avançada , 2006 .

[95]  Alberto Fernández,et al.  Valor pronóstico del índice de masa corporal en pacientes con insuficiencia cardíaca crónica: Registro GESICA , 2006 .

[96]  L. Passos,et al.  [Predictors of in-hospital lethality in patients with advanced heart failure]. , 2006, Arquivos brasileiros de cardiologia.

[97]  M. Montera,et al.  [Prognostic value of the Six-Minute Walk Test in heart failure]. , 2006, Arquivos brasileiros de cardiologia.

[98]  L. Passos,et al.  [Heart failure mortality trend in Salvador, Bahia, Brazil]. , 2005, Arquivos brasileiros de cardiologia.

[99]  Bruno Lococo,et al.  Indicadores clínicos de progresión de la miocarditis chagásica crónica , 2005 .

[100]  A. Mansur,et al.  Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. , 2005, International journal of cardiology.

[101]  S. Macín,et al.  Características clínicas y evolución a largo plazo de pacientes con insuficiencia cardíaca como complicación del infarto agudo de miocardio , 2005 .

[102]  L. Goldraich,et al.  Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United States. , 2005, International journal of cardiology.

[103]  A. C. P. Barretto,et al.  Repercussão nutricional na insuficiência cardíaca avançada e seu valor na avaliação prognóstica , 2005 .

[104]  S. Rassi,et al.  [Survival and prognostic factors in systolic heart failure with recent symptom onset]. , 2005, Arquivos brasileiros de cardiologia.

[105]  L. Cámera,et al.  [Prevention of cardiovascular diseases by an antihypertensive program in the elderly, a cohort study]. , 2005, Anales de medicina interna.

[106]  Eduardo R Perna,et al.  Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. , 2005, International journal of cardiology.

[107]  J. Granados,et al.  Tumour Necrosis Factor alpha and Troponin T as predictors of poor prognosis in patients with stable heart failure. , 2005, Clinical and investigative medicine. Medecine clinique et experimentale.

[108]  Jorge Thierer,et al.  Registro Nacional de internación por insuficiencia cardíaca 2002-2003 , 2004 .

[109]  Albert Hofman,et al.  Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. , 2004, European heart journal.

[110]  E. Mesquita.  [Heart failure in Brazil. The EPICA-Niteroi study]. , 2004, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[111]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[112]  G. Rosano,et al.  Long-term prognostic value of triiodothyronine concentration in elderly patients with heart failure. , 2003, The American journal of geriatric cardiology.

[113]  F. Fuchs,et al.  Risk factors for cardiovascular disease in a Brazilian population-based cohort study. , 2003, International journal of cardiology.

[114]  I. Squire,et al.  Prognosis for patients newly admitted to hospital with heart failure: survival trends in 12 220 index admissions in Leicestershire 1993–2001 , 2003, Heart.

[115]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[116]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[117]  John A Spertus,et al.  Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. , 2002, Journal of the American College of Cardiology.

[118]  I. Olkin,et al.  Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .

[119]  T. Martin,et al.  The prevalence, aetiology and treatment of congestive cardiac failure in Antigua and Barbuda. , 1999, The West Indian medical journal.

[120]  S G Thompson,et al.  Incidence and aetiology of heart failure; a population-based study. , 1999, European heart journal.

[121]  D. Grobbee,et al.  An epidemic of heart failure? Recent evidence from Europe. , 1998, European heart journal.

[122]  E. Mesquita,et al.  Evolução intra-hospitalar e seguimento pós-alta de pacientes idosos atendidos com insuficiência cardíaca congestiva na unidade de emergência , 1998 .

[123]  R. Bonow,et al.  Chronic heart failure in the United States: a manifestation of coronary artery disease. , 1998, Circulation.

[124]  D. Sackett,et al.  Cochrane Collaboration , 1994, BMJ.

[125]  F. Pileggi,et al.  Survival and Predictors of Survival in Patients With Congestive Heart Failure Due to Chagas' Cardiomyopathy , 1994, Circulation.

[126]  F G Fowkes,et al.  Critical appraisal of published research: introductory guidelines. , 1991, BMJ.

[127]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[128]  J. Tukey,et al.  Transformations Related to the Angular and the Square Root , 1950 .

[129]  M. Wensing,et al.  Trends and predictors of hospitalization, readmissions and length of stay in ambulatory patients with heart failure. , 2013, Revista clinica espanola.

[130]  Mark D. Huffman,et al.  Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association. , 2013, Circulation.

[131]  J. Ramires,et al.  Role of BNP levels on the prognosis of decompensated advanced heart failure. , 2013, Arquivos brasileiros de cardiologia.

[132]  Pedro Alves Lemos Neto,et al.  In-hospital Outcomes of Patients with Cardiogenic Shock due to ST-Segment Elevation Myocardial Infarction , 2013 .

[133]  E. Mesquita,et al.  β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity. , 2013, Molecular medicine reports.

[134]  R. Bestetti,et al.  Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy. , 2011, Arquivos brasileiros de cardiologia.

[135]  D. Almeida,et al.  Hospitalization and mortality rates for heart failure in public hospitals in São Paulo. , 2011, Arquivos brasileiros de cardiologia.

[136]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[137]  E. Bocchi,et al.  Physical activity profile in heart failure patients from a Brazilian tertiary cardiology hospital. , 2010, Cardiology journal.

[138]  E. Colín-Ramírez,et al.  Prognostic value of cardiac troponin T elevation is independent of renal function and clinical findings in heart failure patients. , 2010, Cardiology journal.

[139]  G. Oliveira,et al.  [Mortality due to heart failure: extended analysis and temporal trend in three states of Brazil]. , 2010, Arquivos brasileiros de cardiologia.

[140]  M. Cheitlin.  Prospective Validation of the Prognostic Usefulness of Brain Natriuretic Peptide in Asymptomatic Patients With Chronic Severe Mitral Regurgitation , 2010 .

[141]  L. Goldraich,et al.  Clinical predictors of preserved left ventricular ejection fraction in decompensated heart failure. , 2010, Arquivos brasileiros de cardiologia.

[142]  A. H. Santo.  [Chagas disease-related mortality trends, state of São Paulo, Brazil, 1985 to 2006: a study using multiple causes of death]. , 2009, Revista panamericana de salud publica = Pan American journal of public health.

[143]  A. Lancheros,et al.  Insuficiencia cardíaca aguda: factores asociados con mortalidad. Hospital de San José, julio 2007 - agosto 2008 Bogotá D.C. Colombia , 2009 .

[144]  R. Caballero,et al.  Cardiac power as prognostic marker in cardiogenic shock in acute myocardial infarction , 2009 .

[145]  Jorge Thierermtsac,et al.  National Registry of Admissions due to Heart Failure , 2009 .

[146]  Alejandro Macchia,et al.  CARMELA: assessment of cardiovascular risk in seven Latin American cities. , 2008, The American journal of medicine.

[147]  M. Moreira,et al.  Favorable effects of the optimized drug treatment of heart failure on ventricular arrhythmias. , 2008, Arquivos brasileiros de cardiologia.

[148]  E. Bocchi,et al.  Decompensated heart failure in the emergency department of a cardiology hospital. , 2008, Arquivos brasileiros de cardiologia.

[149]  M. O. Oliveira Júnior,et al.  Why do patients with chagasic cardiomyopathy have worse outcomes than those with non-chagasic cardiomyopathy? , 2008, Arquivos brasileiros de cardiologia.

[150]  G. Aliti,et al.  Non-pharmacological management of patients hospitalized with heart failure at a teaching hospital. , 2006, Arquivos brasileiros de cardiologia.

[151]  D. Dragosavac,et al.  Severe heart failure at intensive therapy unit--is there an ideal prognostic index? , 2006, Arquivos brasileiros de cardiologia.

[152]  R. Bestetti,et al.  QT interval dispersion in patients with chronic heart failure secondary to Chagas' cardiomyopathy: correlation with clinical variables of prognostic significance. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[153]  A. Barbagelata,et al.  Overview of acute decompensated heart failure in Argentina: lessons learned from 5 registries during the last decade. , 2006, American heart journal.

[154]  D. M. Moreira,et al.  Insuficiência cardíaca: mortalidade intra-hospitalar e sobrevida de 1 ano , 2006 .

[155]  E. Mesquita,et al.  [Anemia as a prognostic factor in a population hospitalized due to decompensated heart failure]. , 2005, Arquivos brasileiros de cardiologia.

[156]  E. Mesquita,et al.  Epidemiology of decompensated heart failure in the city of Niterói: EPICA - Niterói Project. , 2004, Arquivos brasileiros de cardiologia.

[157]  G. Bonsel,et al.  Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. , 1994, American journal of public health.